Similar articles

• Cytochrome oxidase deficiency: clinical and biochemical heterogeneity.

  DiMauro S, Zeviani M, Servidei S, Bonilla E, Miranda AF, Prelle A, Schon EA. DiMauro S, et al. Ann N Y Acad Sci. 1986;488:19-32. doi: 10.1111/j.1749-6632.1986.tb46545.x. Ann N Y Acad Sci. 1986. PMID: 3034115 Review. No abstract available.
• Complementation analysis of systemic cytochrome oxidase deficiency presenting as Leigh syndrome.

  Brown RM, Brown GK. Brown RM, et al. J Inherit Metab Dis. 1996;19(6):752-60. doi: 10.1007/BF01799168. J Inherit Metab Dis. 1996. PMID: 8982948
• Human cytochrome oxidase deficiency.

  Robinson BH. Robinson BH. Pediatr Res. 2000 Nov;48(5):581-5. doi: 10.1203/00006450-200011000-00004. Pediatr Res. 2000. PMID: 11044474 Review.
• A novel mutation in SURF1 causes skipping of exon 8 in a patient with cytochrome c oxidase-deficient leigh syndrome and hypertrichosis.

  Williams SL, Taanman JW, Hansíková H, Houst'ková H, Chowdhury S, Zeman J, Houstek J. Williams SL, et al. Mol Genet Metab. 2001 Aug;73(4):340-3. doi: 10.1006/mgme.2001.3206. Mol Genet Metab. 2001. PMID: 11509016
• Pyruvate therapy for Leigh syndrome due to cytochrome c oxidase deficiency.

  Komaki H, Nishigaki Y, Fuku N, Hosoya H, Murayama K, Ohtake A, Goto Y, Wakamoto H, Koga Y, Tanaka M. Komaki H, et al. Biochim Biophys Acta. 2010 Mar;1800(3):313-5. doi: 10.1016/j.bbagen.2009.07.008. Epub 2009 Jul 17. Biochim Biophys Acta. 2010. PMID: 19616603